Brief: USANA Health Sciences Q3 EPS USD 0.59
24/10/2023 21:05
Oct 24 (Reuters) - USANA Health Sciences Q3 sales USD 213.365 million. * Q3 net earnings USD 11.347 million * Q3 earnings from operations USD 17.607 million * Q3 gross profit USD 170.836 million * Q3 pretax profit USD 20.531 million * outlook FY EPS USD 2.8-3.05 * outlook FY sales USD 900-920 million
Recent news on USANA Health Sciences
See all newsBrief: Usana Schedules Third Quarter 2026 Earnings Release And Conference Call
Brief: Usana Health Sciences - Enters First Amendment To Credit Agreement On Sept 30, 2026 - SEC Filing
USANA Health Sciences Q2 sales fall amid weaker Hiya and Rise performance
Brief: USANA Health Sciences Q2 EPS USD -1.16
Usana Health Sciences Inc Expected To Post Earnings Of 43 Cents A Share: Earnings Preview